Evidence map›Paper›PMID 19013149›Full record

ReviewExperimental cell research2009

The role of protease activity in ErbB biology.

Carl P Blobel, Graham Carpenter, Matthew Freeman

Open access · greenAbstract readReview
In one paragraph

Review in Experimental cell research, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 81 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Genetic Modification of CD8Frontiers in immunology · 2019
    Article
  11. Frequency, impact and a preclinical study of novelTherapeutic advances in medical oncology · 2018
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. ADAM Proteases and Gastrointestinal Function.Annual review of physiology · 2016
    Review
  18. Article
  19. Article
  20. iRhoms 1 and 2 are essential upstream regulators of ADAM17-dependent EGFR signaling.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Carl P BlobelArthritis and Tissue Degeneration Program, Hospital for Special Surgery, Department of Medicine, Weil Medical College of Cornell University, New York, NY 10021, USA. blobelc@hss.edu
Graham Carpenter
Matthew Freeman
Cornell University · USMRC Laboratory of Molecular Biology · GBVanderbilt University · US

Funding

iRhoms 1 and 2: Key regulators of ADAM17-dependent EGFR signalingR01GM064750 · NIGMS · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI BLOBEL, CARL PETER · 2002 to 2019
$6.1M
Role of ADAMs 9 and 15 in Proliferative RetinopathyR01EY015719 · NEI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI BLOBEL, CARL PETER · 2004 to 2009
$2.5M
Role of the Sec61 Translocon in EGF Receptor Trafficking and SignalingR01CA125649 · NCI · VANDERBILT UNIVERSITY · PI CARPENTER, GRAHAM F · 2008 to 2012
$1.6M
NCI NIH HHS CA125649NCI NIH HHS R01 CA125649NEI NIH HHS EY015719NEI NIH HHS R01 EY015719NIGMS NIH HHS GM647450NIGMS NIH HHS R01 GM064750
6 · The paper itself

Abstract

Proteases are now recognized as having an active role in a variety of processes aside from their recognized metabolic role in protein degradation. Within the ErbB system of ligands and receptors, proteases are known to be necessary for the generation of soluble ligands from transmembrane precursors and for the processing of the ErbB4 receptor, such that its intracellular domain is translocated to the nucleus. There are two protease activities involved in the events: proteases that cleave within the ectodomain of ligand (or receptor) and proteases that cleave the substrate within the transmembrane domain. The former are the ADAM proteases and the latter are the gamma-secretase complex and the rhomboid proteases. This review discusses the roles of each of these protease systems within the ErbB system.

Indexed as

ADAM ProteinsAmyloid Precursor Protein SecretasesAnimalsErb-b2 Receptor Tyrosine KinasesHumansMembrane ProteinsModels, MolecularPeptide HydrolasesProtein TransportSignal TransductionSubstrate SpecificityADAM ProteinsAmyloid Precursor Protein SecretasesErb-b2 Receptor Tyrosine KinasesMembrane ProteinsPeptide Hydrolases

Identifiers

PMID19013149
PMCPMC2646910
OpenAlexW1987457606

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.